المؤلفون: Bullement, A, Nathan, P, Willis, A, Amin, A, Lilley, C, Stapelkamp, C, Hatswell, A, Pescott, C, Bharmal, M

المصدر: PharmacoEconomics - Open , 3 pp. 377-390. (2019)

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10067291/1/Bullement2019_Article_CostEffectivenessOfAvelumabFor.pdf; https://discovery.ucl.ac.uk/id/eprint/10067291/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10067291/1/Bullement2019_Article_CostEffectivenessOfAvelumabFor.pdf
https://discovery.ucl.ac.uk/id/eprint/10067291/

المؤلفون: Bullement, A., Nathan, P., Willis, A., Amin, A., Lilley, C., Stapelkamp, C., Hatswell, A., Pescott, C., Bharmal, M.

وصف الملف: text

Relation: https://eprints.whiterose.ac.uk/169366/1/Cost%20Effectiveness%20of%20Avelumab%20for%20Metastatic%20Merkel%20Cell%20Carcinoma.pdf; Bullement, A. orcid.org/0000-0001-7091-0972 , Nathan, P., Willis, A. et al. (6 more authors) (2019) Cost effectiveness of Avelumab for metastatic Merkel cell carcinoma. PharmacoEconomics - Open, 3 (3). pp. 377-390. ISSN 2509-4262

الاتاحة: https://eprints.whiterose.ac.uk/169366/
https://eprints.whiterose.ac.uk/169366/1/Cost%20Effectiveness%20of%20Avelumab%20for%20Metastatic%20Merkel%20Cell%20Carcinoma.pdf

المؤلفون: Bullement, A., Amin, A., Stapelkamp, C., Willis, A., Lilley, C., Hatswell, A.J., Pescott, C., Bharmal, M.

المصدر: Value in Health ; volume 21, page S11 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2018.09.062
https://api.elsevier.com/content/article/PII:S109830151833362X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S109830151833362X?httpAccept=text/plain

المؤلفون: Bharmal, M., Amin, A., Stapelkamp, C., Pescott, C., Hatswell, A., Lilley, C., Bullement, A., Willis, A.

المصدر: Annals of Oncology ; volume 29, page viii461 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdy289.047
https://api.elsevier.com/content/article/PII:S0923753419497469?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419497469?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy289.047/26139396/mdy289.047.pdf

المؤلفون: Kontoudis, I., Harries, M., Mohr, P., Grange, F., Ehness, R., Benjamin, L., Siakpere, O., Barth, J., Stapelkamp, C., Pfersch, S., McLeod, L., Kaye, J.A., Wolowacz, S.

المصدر: Value in Health ; volume 17, issue 7, page A626 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2014.08.2227
https://api.elsevier.com/content/article/PII:S1098301514041576?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301514041576?httpAccept=text/plain

المؤلفون: Delea, T.E, Amdahl, J., Wang, A., Amonkar, M., Smith, H.W., Balaratnam, S., Stapelkamp, C.

المصدر: Value in Health ; volume 17, issue 3, page A88 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2014.03.514
https://api.elsevier.com/content/article/PII:S1098301514005658?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301514005658?httpAccept=text/plain

المؤلفون: Vouk, K., Benter, U., Amonkar, M., Stapelkamp, C.

المصدر: Value in Health ; volume 17, issue 3, page A81 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2014.03.472
https://api.elsevier.com/content/article/PII:S1098301514005233?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301514005233?httpAccept=text/plain

المؤلفون: Bullement, A., D'Angelo, S.P., Amin, A., Stapelkamp, C., Willis, A., Lilley, C., Hatswell, A., Bharmal, M.

Relation: Bullement, A. orcid.org/0000-0001-7091-0972 , D'Angelo, S.P., Amin, A. et al. (5 more authors) (2018) Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab. In: Journal of Clinical Oncology. 2018 ASCO Annual Meeting, 01-05 Jun 2018, Chicago, IL, USA. American Society of Clinical Oncology .

الاتاحة: https://eprints.whiterose.ac.uk/169367/

المؤلفون: Bullement, A., Amin, A., Stapelkamp, C., Willis, A., Lilley, C., Hatswell, A.J., Pescott, C., Bharmal, M.

وصف الملف: text

Relation: https://eprints.whiterose.ac.uk/169363/1/ISPOR%20Podium%20%28Avelumab%29.pdf; Bullement, A. orcid.org/0000-0001-7091-0972 , Amin, A., Stapelkamp, C. et al. (5 more authors) (2018) Modelling overall survival in immunotherapy using parametric techniques : Avelumab in previously treated metastatic Merkel cell carcinoma. In: Value in Health. ISPOR 21st Annual European Meeting, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S11-S11.

الاتاحة: https://eprints.whiterose.ac.uk/169363/
https://eprints.whiterose.ac.uk/169363/1/ISPOR%20Podium%20%28Avelumab%29.pdf

المؤلفون: Bloor, A, De, Cock E, Hatswell, AJ, Wasiak, R, Elvidge, J, Stapelkamp, C, Hadjivassileva, T, Haiderali, A, Delgado, J

المصدر: Bloor , A , De , C E , Hatswell , AJ , Wasiak , R , Elvidge , J , Stapelkamp , C , Hadjivassileva , T , Haiderali , A & Delgado , J 2015 , ' Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL) ' , British Journal of Haematology , vol. 169 , no. 3 . https://doi.org/10.1111/bjh.13224

الاتاحة: https://research.manchester.ac.uk/en/publications/27894fe3-4106-4e20-8e9f-409c190084b4
https://doi.org/10.1111/bjh.13224

المؤلفون: Stapelkamp, C¹, Byrne, B¹, van Hout, B²

المصدر: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA394-A394. 1p.